Literature DB >> 11014329

Magnetic resonance assessment of acute and chronic stroke.

K M Welch1, Y Cao, V Nagesh.   

Abstract

This article describes the important role of magnetic resonance imaging (MRI) in noninvasively assessing human focal ischemic stroke. Conventional MRI, diffusion-weighted and/or perfusion-weighted imaging have been used to facilitate both the qualitative and quantitative evaluation of heterogeneity of ischemic brain tissue. Further, by combining 2 or more magnetic resonance parameters, tissue-signature models have been developed that may be used as surrogate markers of tissue histopathology to characterize ischemic tissue as salvageable, necrotic, or tissue in transition to necrosis. Magnetic resonance tissue-signature models and results are presented. Dynamic changes in the evolution of ischemic tissue to infarction are also discussed. Recovery from acute stroke was studied with blood oxygenation level-dependent functional MRI to investigate the neural mechanisms for recovery from aphasia after stroke.

Entities:  

Mesh:

Year:  2000        PMID: 11014329     DOI: 10.1053/pcad.2000.9029

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  3 in total

1.  Design, data management, and population baseline characteristics of the PERFORM magnetic resonance imaging project.

Authors:  P Maeder; L Bracoud; H Chabriat; A Gass; P Michel; M Hennerici
Journal:  J Neurol       Date:  2010-12-03       Impact factor: 4.849

2.  Topography of acute stroke in a sample of 439 right brain damaged patients.

Authors:  Christoph Sperber; Hans-Otto Karnath
Journal:  Neuroimage Clin       Date:  2015-11-17       Impact factor: 4.881

3.  Comparison of the neuropoietic activity of gene-modified versus parental mesenchymal stromal cells and the identification of soluble and extracellular matrix-related neuropoietic mediators.

Authors:  Irina Aizman; Brenna J Tirumalashetty; Michael McGrogan; Casey C Case
Journal:  Stem Cell Res Ther       Date:  2014-02-26       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.